These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
187 related articles for article (PubMed ID: 27869743)
1. A Metal-Free Regioselective Multicomponent Approach for the Synthesis of Free Radical Scavenging Pyrimido-Fused Indazoles and Their Fluorescence Studies. Palaniraja J; Mohana Roopan S; Mokesh Rayalu G; Abdullah Al-Dhabi N; Valan Arasu M Molecules; 2016 Nov; 21(11):. PubMed ID: 27869743 [TBL] [Abstract][Full Text] [Related]
2. Regioselective Synthesis of Pyranone-Fused Indazoles via Reductive Cyclization and Alkyne Insertion. Wu TY; Dhole S; Selvaraju M; Sun CM ACS Comb Sci; 2018 Mar; 20(3):156-163. PubMed ID: 29381854 [TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel bis(pyrimido[5,4-c]quinoline-2,4(1H,3H)-dione) and its derivatives: evaluation of their antioxidant properties. Parameswaran K; Sivaguru P; Lalitha A Bioorg Med Chem Lett; 2013 Jul; 23(13):3873-8. PubMed ID: 23721805 [TBL] [Abstract][Full Text] [Related]
4. Cu-catalyzed arylation of the amino group in the indazole ring: regioselective synthesis of pyrazolo-carbazoles. Anil Kumar K; Kannaboina P; Dhaked DK; Vishwakarma RA; Bharatam PV; Das P Org Biomol Chem; 2015 Feb; 13(5):1481-91. PubMed ID: 25474646 [TBL] [Abstract][Full Text] [Related]
5. Rhodium(III)-catalyzed indazole synthesis by C-H bond functionalization and cyclative capture. Lian Y; Bergman RG; Lavis LD; Ellman JA J Am Chem Soc; 2013 May; 135(19):7122-5. PubMed ID: 23642256 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and structure-activity relationships of novel pyrimido[1,2-b]indazoles as potential anticancer agents against A-549 cell lines. Yakaiah T; Lingaiah BP; Narsaiah B; Shireesha B; Ashok Kumar B; Gururaj S; Parthasarathy T; Sridhar B Bioorg Med Chem Lett; 2007 Jun; 17(12):3445-53. PubMed ID: 17428660 [TBL] [Abstract][Full Text] [Related]
7. Synthesis of substituted 1H-indazoles from arynes and hydrazones. Li P; Wu C; Zhao J; Rogness DC; Shi F J Org Chem; 2012 Apr; 77(7):3149-58. PubMed ID: 22414117 [TBL] [Abstract][Full Text] [Related]
8. Synthesis of 2-Alkenyl-2H-indazoles from 2-(2-Carbonylmethyl)-2H-indazoles. Lin MH; Liang KY; Tsai CH; Chen YC; Hsiao HC; Li YS; Chen CH; Wu HC Molecules; 2016 Feb; 21(2):238. PubMed ID: 26907234 [TBL] [Abstract][Full Text] [Related]
9. Synthesis of indazoles by the [3+2] cycloaddition of diazo compounds with arynes and subsequent acyl migration. Liu Z; Shi F; Martinez PD; Raminelli C; Larock RC J Org Chem; 2008 Jan; 73(1):219-26. PubMed ID: 18067316 [TBL] [Abstract][Full Text] [Related]
10. Regioselective synthesis of fused imidazo[1,2-a]pyrimidines via intramolecular C-N bond formation/6-endo-dig cycloisomerization. Kumar A; Kumar M; Maurya S; Khanna RS J Org Chem; 2014 Aug; 79(15):6905-12. PubMed ID: 24988318 [TBL] [Abstract][Full Text] [Related]
11. Syntheses of 1-Aryl-5-nitro-1H-indazoles and a General One-Pot Route to 1-Aryl-1H-indazoles. Annor-Gyamfi JK; Gnanasekaran KK; Bunce RA Molecules; 2018 Mar; 23(3):. PubMed ID: 29547568 [TBL] [Abstract][Full Text] [Related]
12. Regioselective protection at N-2 and derivatization at C-3 of indazoles. Luo G; Chen L; Dubowchik G J Org Chem; 2006 Jul; 71(14):5392-5. PubMed ID: 16808535 [TBL] [Abstract][Full Text] [Related]
13. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction. Balwe SG; Jeong YT Org Biomol Chem; 2018 Feb; 16(8):1287-1296. PubMed ID: 29387852 [TBL] [Abstract][Full Text] [Related]
14. Efficient and convenient synthesis of indazol-3(2H)-ones and 2-aminobenzonitriles. Dou G; Shi D J Comb Chem; 2009; 11(6):1073-7. PubMed ID: 19827793 [TBL] [Abstract][Full Text] [Related]
15. Design and structure-activity relationship of 3-benzimidazol-2-yl-1H-indazoles as inhibitors of receptor tyrosine kinases. McBride CM; Renhowe PA; Heise C; Jansen JM; Lapointe G; Ma S; Piñeda R; Vora J; Wiesmann M; Shafer CM Bioorg Med Chem Lett; 2006 Jul; 16(13):3595-9. PubMed ID: 16603352 [TBL] [Abstract][Full Text] [Related]
16. Indazolylpyrazolopyrimidine as highly potent B-Raf inhibitors with in vivo activity. Wang X; Berger DM; Salaski EJ; Torres N; Dutia M; Hanna C; Hu Y; Levin JI; Powell D; Wojciechowicz D; Collins K; Frommer E; Lucas J J Med Chem; 2010 Nov; 53(21):7874-8. PubMed ID: 20961062 [TBL] [Abstract][Full Text] [Related]
17. Domino protocol for the synthesis of diversely functionalized derivatives of a novel fused pentacyclic antioxidant/anticancer fluorescent scaffold: Pyrazolo[5'',1'':2',3']pyrimido[4',5':5,6][1,4]thiazino[2,3-b]quinoxaline. Sheikhi-Mohammareh S; Oroojalian F; Beyzaei H; Moghaddam-Manesh M; Salimi A; Azizollahi F; Shiri A Talanta; 2023 Sep; 262():124723. PubMed ID: 37245433 [TBL] [Abstract][Full Text] [Related]
18. Regioselective synthesis and ab initio calculations of fused heterocycles thermally and under microwave irradiation. Salem ME; Ahmed AA; Shaaban MR; Shibl MF; Farag AM Spectrochim Acta A Mol Biomol Spectrosc; 2015 Sep; 148():175-83. PubMed ID: 25879987 [TBL] [Abstract][Full Text] [Related]
19. DBU-catalyzed, aromatization-oriented, regioselective domino synthesis of 2-aminopyrimidines from β-dicarbonyl compounds, DMF-DMA, and cyanamide. Üngören ŞH; Boz Ş Mol Divers; 2017 Nov; 21(4):925-932. PubMed ID: 28766257 [TBL] [Abstract][Full Text] [Related]
20. Discovery of indazoles as inhibitors of Tpl2 kinase. Hu Y; Cole D; Denny RA; Anderson DR; Ipek M; Ni Y; Wang X; Thaisrivongs S; Chamberlain T; Hall JP; Liu J; Luong M; Lin LL; Telliez JB; Gopalsamy A Bioorg Med Chem Lett; 2011 Aug; 21(16):4758-61. PubMed ID: 21742493 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]